Symptomatic raised intracranial pressure / mass effect in glioblastoma: declining GCS, ne...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-GBM-INTRACRANIAL-PRESSURE-EMERGENCY |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-26 | pending_clinical_signoff |
| Diseases | DIS-GBM |
| Sources | SRC-EANO-GBM-2024 SRC-NCCN-CNS-2025 |
Red Flag Origin
| Definition | Symptomatic raised intracranial pressure / mass effect in glioblastoma: declining GCS, new focal deficit, papilledema, midline shift on imaging, or seizure cluster. Mandates immediate neurosurgical / corticosteroid intervention BEFORE oncologic systemic therapy. |
|---|---|
| Clinical direction | hold |
| Category | organ-dysfunction |
Trigger Logic
{
"any_of": [
{
"finding": "gcs_declining",
"value": true
},
{
"comparator": ">=",
"finding": "midline_shift_mm",
"threshold": 5
},
{
"finding": "uncontrolled_seizure_cluster",
"value": true
},
{
"finding": "new_focal_deficit",
"value": true
}
],
"type": "composite_score"
}
Notes
Mass effect emergency — dexamethasone 8-16 mg IV stat, neurosurgical consult for resection / debulking / VP shunt. Anti-epileptics for seizure cluster (levetiracetam preferred — no enzyme induction vs older AEDs that interfere with TMZ pharmacokinetics).
Used By
Indications
IND-GBM-NEWLY-DIAGNOSED-ELDERLY-HYPORT- IND-GBM-NEWLY-DIAGNOSED-ELDERLY-HYPORTIND-GBM-NEWLY-DIAGNOSED-ELDERLY-TMZ- IND-GBM-NEWLY-DIAGNOSED-ELDERLY-TMZIND-GBM-NEWLY-DIAGNOSED-STUPP- IND-GBM-NEWLY-DIAGNOSED-STUPPIND-GBM-RECURRENT-BEVACIZUMAB- IND-GBM-RECURRENT-BEVACIZUMAB